Inventor · disambiguated record
Stephen K. Doberstein
Also filed as: DOBERSTEIN STEPHEN · DOBERSTEIN STEPHEN K · DOBERSTEIN STEPHEN KOHL · LEE ERNESTINE
20 granted patents·20 pending applications·1,526 citations·filing 1998–2017
96Inventor score
Files withXENCOR INC14FIVE PRIME THERAPEUTICS INC9BEHRENS DIRK3WILLIAMS LEWIS T3BRISTOL MYERS SQUIBB CO2
Top patents by PatentIndex Score
40 records- 0199US8039592B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2007·Granted Oct 18, 2011·86 cites·19 claims
- 0299US7662925B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2006·Granted Feb 16, 2010·349 cites·15 claims
- 0399US7317091B2Optimized Fc variantsXENCOR INC·Filed 2004·Granted Jan 8, 2008·872 cites·1 claims
- 0498US8383109B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2012·Granted Feb 26, 2013·40 cites·4 claims
- 0597US8093357B2Optimized Fc variants and methods for their generationLAZAR GREGORY ALAN·Filed 2006·Granted Jan 10, 2012·51 cites·3 claims
- 0696US8858937B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2013·Granted Oct 14, 2014·20 cites·9 claims
- 0795US10183999B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2016·Granted Jan 22, 2019·10 cites·19 claims
- 0895US7982014B2FGFR3-IIIc fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2010·Granted Jul 19, 2011·24 cites·12 claims
- 0994US8580936B2Polynucleotides encoding FGFR1-IIIc ECD fusion proteinsWILLIAMS LEWIS T·Filed 2011·Granted Nov 12, 2013·40 cites·25 claims
- 1086US8168588B2Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditionsWILLIAMS LEWIS T·Filed 2006·Granted May 1, 2012·8 cites·18 claims
- 1177US8809503B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2013·Granted Aug 19, 2014·1 cites·11 claims
- 1276US9714282B2Optimized Fc variants and methods for their generationXENCOR INC·Filed 2014·Granted Jul 25, 2017·1 cites·8 claims
- 1373US2009286954A1Human cDNA Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their UseFIVE PRIME THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1472US8575312B2Compositions and methods of use for MGD-CSF in disease treatmentBEHRENS DIRK·Filed 2012·Granted Nov 5, 2013·2 cites·11 claims
- 1570US2008182974A1Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their useFIVE PRIME THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 1666US9192683B2Methods of treating disease with FGFR1 fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2013·Granted Nov 24, 2015·0 cites·21 claims
- 1765US9173957B2FGFR2 fusion proteins comprising C-terminal deletion mutants of FGFR2-IIICFIVE PRIME THERAPEUTICS INC·Filed 2013·Granted Nov 3, 2015·0 cites·6 claims
- 1864US2007224192A1OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATIONXENCOR INC·Filed 2007·Application pending·0 cites
- 1964US2017349643A1Compositions and methods of treating disease with fgfr fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2063US8178109B2Compositions and methods of use for MGD-CSF in disease treatmentBEHRENS DIRK·Filed 2009·Granted May 15, 2012·0 cites·12 claims
- 2163US2007219133A1CD52 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATIONXENCOR INC·Filed 2006·Application pending·0 cites
- 2263US2006084799A1Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their useWILLIAMS LEWIS T·Filed 2004·Application pending·0 cites
- 2363US2007224189A1CD20 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATIONXENCOR INC·Filed 2006·Application pending·0 cites
- 2459US2007053901A1Optimized Fc variants and methods for their generationXENCOR INC·Filed 2006·Application pending·0 cites
- 2559US2016096876A1Compositions and methods of treating disease with fgfr fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2659US2004132101A1Optimized Fc variants and methods for their generationXENCOR INC·Filed 2003·Application pending·0 cites
- 2758US6627746B1Nucleic acids and proteins of C. elegans insulin-like genes and uses thereofEXELIXIS INC·Filed 1998·Granted Sep 30, 2003·10 cites·2 claims
- 2857US2014170145A1Compositions and methods of use for mgd-csf in disease treatmentFIVE PRIME THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 2955US6468770B1Nucleic acids and proteins of D. melanogaster insulin-like genes and uses thereofEXELIXIS PHARMACEUTICALS INC·Filed 1998·Granted Oct 22, 2002·11 cites·12 claims
- 3053US2018141997A1Optimized fc variants and methods for their generationXENCOR INC·Filed 2017·Application pending·0 cites
- 3152US2003187246A1Nucleic acids and proteins of C. elegans insulin-like genes and uses thereofFiled 2003·Application pending·0 cites
- 3251US2007264277A1Compositions and Methods of Use for Mgd-Csf in Disease TreatmentBEHRENS DIRK·Filed 2005·Application pending·0 cites
- 3346US2007065883A1Molecules that modulate Galphaq activity and methods of treating urinary incontinenceBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 3446US2010210829A1Compositions and Methods for Treating Diseases, Disorders, or Conditions Characterized by Myelin Degeneration, Myelin Deficiency or LossFIVE PRIME THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3546US2014370021A1OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATIONLAZAR GREGORY ALAN·Filed 2013·Application pending·0 cites
- 3643US7846671B2Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinenceBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Dec 7, 2010·0 cites·6 claims
- 3742US2011319324A1Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseasesLIN JUNYU·Filed 2010·Application pending·0 cites
- 3842US2007054851A1Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseasesLIN JUNYU·Filed 2006·Application pending·0 cites
- 3936US2003068649A1Methods and compositions for the construction and use of fusion librariesFiled 2002·Application pending·0 cites
- 4024US6781028B1Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolismEXELIXIS INC·Filed 1999·Granted Aug 24, 2004·1 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Stephen K. Doberstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →